AKT1 and ulcerative colitis: It’s interesting to note that this served as our primary driving force in our quest to understand the potential therapeutic benefits and underlying mechanisms of the antihistamines CTZ and LOR concerning AA-induced ulcerative colitis and their ability to target PI3k/p-Akt/Nrf2 to be considered as a potential treatment for ulcerative colitis.